TACH 204
Alternative Names: TACH-204Latest Information Update: 10 Apr 2023
At a glance
- Originator Abcellera; Tachyon Therapeutics
- Class Antibodies; Antineoplastics; Immunotherapies
- Mechanism of Action Left right determination factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours